The University of Queensland, UQ Centre for Clinical Research, Herston, Australia.
Pathology. 2011 Jan;43(1):1-8. doi: 10.1097/PAT.0b013e328341e0b5.
Breast cancer is a heterogeneous disease. The traditional classification uses morphology to divide tumours into distinct categories with differing prognosis and behavior. Despite providing high quality data cheaply, it has limitations and hence there has been a hope that the new molecular methods may help to refine the classification systems. Much has been learned in the last few years however, the molecular taxonomy is still in evolution and likely to change over the coming years. Whether the molecular classification is as useful for special subtypes of breast cancers as it has been for ductal carcinoma, no special type, remains to be determined.
乳腺癌是一种异质性疾病。传统的分类方法使用形态学将肿瘤分为不同的类别,具有不同的预后和行为。尽管这种方法提供了高质量的数据,价格也相对便宜,但它存在一定的局限性,因此人们一直希望新的分子方法可以帮助完善分类系统。然而,在过去的几年中,我们已经学到了很多,分子分类学仍在不断发展,并且可能在未来几年发生变化。分子分类对于乳腺癌症的特殊亚型是否像非特殊型导管癌那样有用,还有待确定。